Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Who should not use it without physician consultation, per the label Anyone who is pregnant, nursing, under 18, or currently under treatment for a medical condition
ARNTL2 is a prognostic biomarker and correlates with immune cell infiltration in triple-negative breast cancer
Physicians should consider timely referral to higher levels of care and specialists whenever needed
Potential offlabel or alternative uses discussed in medical settings can include appetite control during weight regain risk periods, or metabolic support in people with insulin resistance, but these uses depend on local regulations and individual medical assessment
US$ 23.48
US$ 27.36
US$ 27.07
US$ 28.04
US$ 26.70
US$ 25.19
US$ 20.60
